Ethan Senturia

Ethan Senturia is the co-founder and CEO of Dealstruck, a San Diego Web platform that matches qualified small-to-medium businesses with lenders in a process that is fair, transparent, and affordable. He previously ran Internet marketing for a lead generation startup, Ampush Media. Ethan joined Lehman Brothers after graduating from the Wharton Business School.

Recent posts

San Diego Startup Week: Moving to Silicon Valley Is Not an Option
When I started Dealstruck, one of the first questions most people would ask me was, “So, when are you moving to The Valley?” Repeatedly I was told, “There is... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

From Our Editors · Special Report
Xcelerating Life Sciences San Diego: Special Report
Learn what's fueling San Diego's biotech investment and partnership opportunities

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients

BioNTech's mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity

Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer’s

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data

CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy

Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing

Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug

Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

Ethan Senturia

Recent posts

San Diego Startup Week: Moving to Silicon Valley Is Not an Option

Underwriters and Partners

The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

Xcelerating Life Sciences San Diego: Special Report

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Xconomy on Demand

We offer a number of ways to subscribe for free!